Cargando…
Emerging recombinant noroviruses identified by clinical and waste water screening
Norovirus is estimated to cause 677 million annual cases of gastroenteritis worldwide, resulting in 210,000 deaths. As viral gastroenteritis is generally self-limiting, clinical samples for epidemiological studies only partially represent circulating noroviruses in the population and is biased towar...
Autores principales: | Lun, Jennifer H., Hewitt, Joanne, Sitabkhan, Alefiya, Eden, John-Sebastian, Enosi Tuipulotu, Daniel, Netzler, Natalie E., Morrell, Leigh, Merif, Juan, Jones, Richard, Huang, Bixing, Warrilow, David, Ressler, Kelly-Anne, Ferson, Mark J., Dwyer, Dominic E., Kok, Jen, Rawlinson, William D., Deere, Daniel, Crosbie, Nicholas D., White, Peter A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874246/ https://www.ncbi.nlm.nih.gov/pubmed/29593246 http://dx.doi.org/10.1038/s41426-018-0047-8 |
Ejemplares similares
-
A Multi-Site Study of Norovirus Molecular Epidemiology in Australia and New Zealand, 2013-2014
por: Lim, Kun Lee, et al.
Publicado: (2016) -
RNA Sequencing of Murine Norovirus-Infected Cells Reveals Transcriptional Alteration of Genes Important to Viral Recognition and Antigen Presentation
por: Enosi Tuipulotu, Daniel, et al.
Publicado: (2017) -
Recombinant GII.P16/GII.4 Sydney 2012 Was the Dominant Norovirus Identified in Australia and New Zealand in 2017
por: Lun, Jennifer H., et al.
Publicado: (2018) -
In silico screening for human norovirus antivirals reveals a novel non-nucleoside inhibitor of the viral polymerase
por: Ferla, Salvatore, et al.
Publicado: (2018) -
The Adenosine Analogue NITD008 has Potent Antiviral Activity against Human and Animal Caliciviruses
por: Enosi Tuipulotu, Daniel, et al.
Publicado: (2019)